© Copyright biotechnewshubb.com All Rights Reserved.
Friday, April 16
››Sana Biotechnology : JPMorgan Starts Sana Biotechnology at Neutral With $35
News

Sana Biotechnology : JPMorgan Starts Sana Biotechnology at Neutral With $35

BioTech News
March 2, 2021
0
13


MT Newswires 2021

All news about SANA BIOTECHNOLOGY, INC.

Sales 2020 –
–
–
Net income 2020 -235 M
–
–
Net cash 2020 18,8 M
–
–
P/E ratio 2020 -18,5x
Yield 2020 –
Capitalization 5 948 M
5 948 M
–
EV / Sales 2020 –
EV / Sales 2021 –
Nbr of Employees 240
Free-Float 87,9%

Chart SANA BIOTECHNOLOGY, INC.

Duration :


Period :

Sana Biotechnology, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends SANA BIOTECHNOLOGY, INC.

Short Term Mid-Term Long Term
Trends Neutral Neutral Neutral

Income Statement Evolution



Read More: Sana Biotechnology : JPMorgan Starts Sana Biotechnology at Neutral With $35

TagsBiotechnologyINC. stock exchangeinformationJPMorganNeutralNewspress releaseSanaSana Biotechnologystarts
Previous Article

Recombinant DNA Technology Market Size 2021

Next Article

Price, New Entrants SWOT Analysis, Competitive Landscape and Gross Margin

Leave a reply

© Copyright Biotechnewshubb.com. All Rights Reserved.